Cargando…

Estimands for factorial trials

Factorial trials offer an efficient method to evaluate multiple interventions in a single trial, however the use of additional treatments can obscure research objectives, leading to inappropriate analytical methods and interpretation of results. We define a set of estimands for factorial trials, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahan, Brennan C., Morris, Tim P., Goulão, Beatriz, Carpenter, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542167/
https://www.ncbi.nlm.nih.gov/pubmed/35751568
http://dx.doi.org/10.1002/sim.9510
_version_ 1784804088516444160
author Kahan, Brennan C.
Morris, Tim P.
Goulão, Beatriz
Carpenter, James
author_facet Kahan, Brennan C.
Morris, Tim P.
Goulão, Beatriz
Carpenter, James
author_sort Kahan, Brennan C.
collection PubMed
description Factorial trials offer an efficient method to evaluate multiple interventions in a single trial, however the use of additional treatments can obscure research objectives, leading to inappropriate analytical methods and interpretation of results. We define a set of estimands for factorial trials, and describe a framework for applying these estimands, with the aim of clarifying trial objectives and ensuring appropriate primary and sensitivity analyses are chosen. This framework is intended for use in factorial trials where the intent is to conduct “two‐trials‐in‐one” (ie, to separately evaluate the effects of treatments A and B), and is comprised of four steps: (i) specifying how additional treatment(s) (eg, treatment B) will be handled in the estimand, and how intercurrent events affecting the additional treatment(s) will be handled; (ii) designating the appropriate factorial estimator as the primary analysis strategy; (iii) evaluating the interaction to assess the plausibility of the assumptions underpinning the factorial estimator; and (iv) performing a sensitivity analysis using an appropriate multiarm estimator to evaluate to what extent departures from the underlying assumption of no interaction may affect results. We show that adjustment for other factors is necessary for noncollapsible effect measures (such as odds ratio), and through a trial re‐analysis we find that failure to consider the estimand could lead to inappropriate interpretation of results. We conclude that careful use of the estimands framework clarifies research objectives and reduces the risk of misinterpretation of trial results, and should become a standard part of both the protocol and reporting of factorial trials.
format Online
Article
Text
id pubmed-9542167
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95421672022-10-14 Estimands for factorial trials Kahan, Brennan C. Morris, Tim P. Goulão, Beatriz Carpenter, James Stat Med Research Articles Factorial trials offer an efficient method to evaluate multiple interventions in a single trial, however the use of additional treatments can obscure research objectives, leading to inappropriate analytical methods and interpretation of results. We define a set of estimands for factorial trials, and describe a framework for applying these estimands, with the aim of clarifying trial objectives and ensuring appropriate primary and sensitivity analyses are chosen. This framework is intended for use in factorial trials where the intent is to conduct “two‐trials‐in‐one” (ie, to separately evaluate the effects of treatments A and B), and is comprised of four steps: (i) specifying how additional treatment(s) (eg, treatment B) will be handled in the estimand, and how intercurrent events affecting the additional treatment(s) will be handled; (ii) designating the appropriate factorial estimator as the primary analysis strategy; (iii) evaluating the interaction to assess the plausibility of the assumptions underpinning the factorial estimator; and (iv) performing a sensitivity analysis using an appropriate multiarm estimator to evaluate to what extent departures from the underlying assumption of no interaction may affect results. We show that adjustment for other factors is necessary for noncollapsible effect measures (such as odds ratio), and through a trial re‐analysis we find that failure to consider the estimand could lead to inappropriate interpretation of results. We conclude that careful use of the estimands framework clarifies research objectives and reduces the risk of misinterpretation of trial results, and should become a standard part of both the protocol and reporting of factorial trials. John Wiley & Sons, Inc. 2022-06-25 2022-09-30 /pmc/articles/PMC9542167/ /pubmed/35751568 http://dx.doi.org/10.1002/sim.9510 Text en © 2022 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Kahan, Brennan C.
Morris, Tim P.
Goulão, Beatriz
Carpenter, James
Estimands for factorial trials
title Estimands for factorial trials
title_full Estimands for factorial trials
title_fullStr Estimands for factorial trials
title_full_unstemmed Estimands for factorial trials
title_short Estimands for factorial trials
title_sort estimands for factorial trials
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542167/
https://www.ncbi.nlm.nih.gov/pubmed/35751568
http://dx.doi.org/10.1002/sim.9510
work_keys_str_mv AT kahanbrennanc estimandsforfactorialtrials
AT morristimp estimandsforfactorialtrials
AT goulaobeatriz estimandsforfactorialtrials
AT carpenterjames estimandsforfactorialtrials